Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial

Antenatal corticosteroids (ACSs) administered to women before preterm birth improve neonatal health. Proportionately more women are obese or overweight in current obstetric populations than those who were included in the original trials of ACSs, and it remains uncertain if higher doses are required for such women.Our aim was to assess the association between maternal body mass index (BMI) and infant morbidity after the administration of ACSs.In...